O-antigen of Salmonella enterica serovar Paratyphi A (SPA O-antigen)

The O-antigen of Salmonella enterica serovar Paratyphi A is the primary surface-exposed polysaccharide component of the lipopolysaccharide (LPS) layer on the bacterial outer membrane. It defines the serological identity of the pathogen as Serogroup A (O:2) and is characterized by a repeating oligosaccharide unit containing paratose, rhamnose, mannose, and galactose. Biologically, the O-antigen is essential for bacterial virulence, providing a shield against host immune mechanisms such as complement-mediated lysis and phagocytosis. It also contributes to the structural integrity of the cell wall and serves as a receptor for certain bacteriophages. In clinical medicine, Salmonella Paratyphi A is a major cause of paratyphoid fever, a systemic enteric disease that is increasingly prevalent and often resistant to multiple antibiotics. Because the O-antigen is highly immunogenic and specific to the pathogen, it is the central target for next-generation vaccines, including live attenuated strains and glycoconjugates. These vaccines aim to elicit high titers of O-specific antibodies that facilitate the clearance of the bacteria from the bloodstream and prevent systemic infection. Therapeutic strategies focusing on this target are critical for addressing the global burden of enteric fever, especially in regions where antibiotic resistance is high.

Other names

O-polysaccharide of Salmonella Paratyphi AO:2 antigenLPS O-antigenGroup A O-antigenSalmonella Paratyphi A O-specific chain

Vaccines targeting the O-antigen induce the production of O-specific serum IgG and IgA antibodies that promote opsonophagocytosis and complement-mediated bactericidal activity against Salmonella Paratyphi A.